Nomura Holdings’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Hold
0
779
2025
Q1
Hold
0
1024
2024
Q4
Sell
-17,849
Closed -$4.91M 1473
2024
Q3
$4.91M Buy
17,849
+11,423
+178% +$3.14M 0.01% 298
2024
Q2
$1.56M Buy
+6,426
New +$1.56M ﹤0.01% 488
2023
Q4
Hold
0
1146
2023
Q3
Sell
-1,572
Closed -$299K 798
2023
Q2
$299K Sell
1,572
-10,779
-87% -$2.05M ﹤0.01% 589
2023
Q1
$2.47M Buy
+12,351
New +$2.47M 0.01% 367
2022
Q4
Sell
-6,113
Closed -$1.23M 1050
2022
Q3
$1.23M Sell
6,113
-11,330
-65% -$2.27M 0.01% 536
2022
Q2
$2.58M Buy
+17,443
New +$2.58M 0.01% 444
2022
Q1
Sell
-22,403
Closed -$3.81M 1467
2021
Q4
$3.81M Buy
22,403
+20,674
+1,196% +$3.52M 0.01% 482
2021
Q3
$332K Sell
1,729
-1,993
-54% -$383K ﹤0.01% 1155
2021
Q2
$631K Sell
3,722
-2,700
-42% -$458K ﹤0.01% 877
2021
Q1
$907K Sell
6,422
-12,800
-67% -$1.81M ﹤0.01% 792
2020
Q4
$2.5M Buy
+19,222
New +$2.5M ﹤0.01% 491
2018
Q1
Sell
-5,488
Closed -$698K 1006
2017
Q4
$698K Buy
+5,488
New +$698K ﹤0.01% 760
2016
Q1
Sell
-10,096
Closed -$951K 1139
2015
Q4
$951K Buy
10,096
+100
+1% +$9.42K ﹤0.01% 456
2015
Q3
$785K Sell
9,996
-69,075
-87% -$5.42M ﹤0.01% 470
2015
Q2
$9.05M Buy
+79,071
New +$9.05M 0.03% 135
2014
Q4
Sell
-2,690
Closed -$206K 1478
2014
Q3
$206K Buy
2,690
+2,687
+89,567% +$206K ﹤0.01% 1559
2014
Q2
$0 Buy
+3
New ﹤0.01% 1902
2014
Q1
Sell
-3,509
Closed -$225K 1919
2013
Q4
$225K Sell
3,509
-28,399
-89% -$1.82M ﹤0.01% 1592
2013
Q3
$2.05M Buy
+31,908
New +$2.05M 0.01% 737